Clinical Trial Update: Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED) [Phase 2]

View source ↗

Summary

Phase 2 PROCEED trial evaluating pembrolizumab with radiotherapy and chemotherapy as neoadjuvant treatment for locally advanced esophageal and gastric cancers; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Duke University | Conditions: Locally Advanced Esophageal and Gastric Cancers (EGC) | Phase 2 | Status: COMPLETED | Results posted: 2024-03-13